GeneReach Biotechnology Corp. (TPEX:4171)

GeneReach Biotechnology Statistics

Total Valuation

TPEX:4171 has a market cap or net worth of TWD 1.12 billion. The enterprise value is 1.06 billion.

Market Cap	1.12B
Enterprise Value	1.06B

Important Dates

The last earnings date was Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:4171 has 57.30 million shares outstanding. The number of shares has decreased by -0.79% in one year.

Current Share Class	57.30M
Shares Outstanding	57.30M
Shares Change (YoY)	-0.79%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	5.25%
Owned by Institutions (%)	0.13%
Float	42.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.81
PB Ratio	1.88
P/TBV Ratio	1.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.61
EV / Sales	4.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-53.33

Financial Position

The company has a current ratio of 2.41, with a Debt / Equity ratio of 0.37.

Current Ratio	2.41
Quick Ratio	1.65
Debt / Equity	0.37
Debt / EBITDA	n/a
Debt / FCF	-11.03
Interest Coverage	-12.28

Financial Efficiency

Return on equity (ROE) is -17.08% and return on invested capital (ROIC) is -14.76%.

Return on Equity (ROE)	-17.08%
Return on Assets (ROA)	-5.13%
Return on Invested Capital (ROIC)	-14.76%
Return on Capital Employed (ROCE)	-11.75%
Weighted Average Cost of Capital (WACC)	6.34%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.24
Inventory Turnover	2.05

Taxes

Income Tax	-3.54M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.98% in the last 52 weeks. The beta is 0.52, so TPEX:4171's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	+5.98%
50-Day Moving Average	19.75
200-Day Moving Average	19.81
Relative Strength Index (RSI)	55.18
Average Volume (20 Days)	137,102

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4171 had revenue of TWD 232.74 million and -110.28 million in losses. Loss per share was -1.93.

Revenue	232.74M
Gross Profit	160.93M
Operating Income	-79.86M
Pretax Income	-116.47M
Net Income	-110.28M
EBITDA	-22.24M
EBIT	-79.86M
Loss Per Share	-1.93

Balance Sheet

The company has 289.76 million in cash and 219.10 million in debt, with a net cash position of 70.67 million or 1.23 per share.

Cash & Cash Equivalents	289.76M
Total Debt	219.10M
Net Cash	70.67M
Net Cash Per Share	1.23
Equity (Book Value)	596.72M
Book Value Per Share	10.24
Working Capital	283.03M

Cash Flow

In the last 12 months, operating cash flow was -13.52 million and capital expenditures -6.36 million, giving a free cash flow of -19.87 million.

Operating Cash Flow	-13.52M
Capital Expenditures	-6.36M
Depreciation & Amortization	57.62M
Net Borrowing	-46.19M
Free Cash Flow	-19.87M
FCF Per Share	-0.35

Margins

Gross margin is 69.14%, with operating and profit margins of -34.31% and -47.38%.

Gross Margin	69.14%
Operating Margin	-34.31%
Pretax Margin	-50.04%
Profit Margin	-47.38%
EBITDA Margin	-9.56%
EBIT Margin	-34.31%
FCF Margin	n/a

Dividends & Yields

TPEX:4171 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.79%
Shareholder Yield	0.79%
Earnings Yield	-9.84%
FCF Yield	-1.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 28, 2023. It was a forward split with a ratio of 1.25.

Last Split Date	Jul 28, 2023
Split Type	Forward
Split Ratio	1.25

Scores

TPEX:4171 has an Altman Z-Score of 2.81 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.81
Piotroski F-Score	3